{"name":"Novoteris, LLC","slug":"novoteris-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPcGtMcWJwOTNqNFhlZW9TNE9ONkdTMU53NlEtejAycjFwWHlWV3hXXzB3Q1BocGZUVjlUcWE4TjBka0tseXZmT2tLajQ0d1ZHeHpDbEVRTENZZlNwaWsxM2pUdWRyRDJ0SHluRHppWjkybndFazdGUFoyNlBMUHhXRS1RN1U5VHoya3RCNXRmMzVTV2RzWkx3WVRwVnU3cXl6Nm1WN2xqazN3UHAtRTdpXy1MTHd4Z1FnRzhydmJUTDV3VENPM3gzaHhZV0Y?oc=5","date":"2020-04-30","type":"trial","source":"multivu.com","summary":"Mallinckrodt Supports Investigator-Initiated Study at Massachusetts General - multivu.com","headline":"Mallinckrodt Supports Investigator-Initiated Study at Massachusetts General","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wJBVV95cUxQeDY0QUdrMmhXQnVTYnozR0VaR0M5TEhCZjRTa2YxdzRsdlIxUTRpVW11VGlXMF9CaEdVandLZGpfUXlnZWc3bHUxbUFCUUFXWlZMOWo0d3pUTEd6OEw2TVBZTTE2Y2xkR1dIMXlGTE0xSkJoYVZwSDJ1Nk9qODJZRWkzVFZnTkFVRER3ZUQ4U3ZKOUUtU0FTcjkzRGplVHdZekg5ajE3SWsyTEhlZTFMV2E2ZWpvMXhKT2h1Y19SandWdFBmYUVsWDZRbXNhV21vM0o4SzgxR3prdzU3b0RJeVpVSWZpNlltdUNiZ2dhdS1Ma2ZweDc4WE1jRm1pS0k4eE51QVdwNi16Mm9QRXdNRndEWVpfa0FyVzcxc1ZQYi1zRHc2M0pCQk9LdVpiZl9vRjRlOFUwWlZMN0pxR1dmaU9UdGFPMTN3d1ZxMTg1dm9KVWt0ZE5rX0l0dw?oc=5","date":"2020-04-01","type":"trial","source":"prnewswire.com","summary":"Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide Therapy for COVID-19 Infection and Associated Lung Complications - prnewswire.com","headline":"Mallinckrodt and Novoteris Receive Clearance from Health Canada to Start Pilot Trial of High-Dose Inhaled Nitric Oxide T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxPNVgzbnJfSU5XREdENUdFMXp4SWVNeF9pbldudkFXUTJweVdnaDNDTC1KTmltcDYtUGE3WEM5alFmcFZNNFg2Vng4V05hZGctOWpuWmNVa3RzWXFrSy1xSWMxVnNoNTNFX3VaTGNXcERKZ1pGSU5tRVRQcnNsZE9rLW4xUTZBaWpRVUxXd3NlSnhDeFZCMGhSWFh6SnVjMWdGeFE0S0h2SC16MER0UGJqQjJCOUhxeFlqcnQ5TS1IMFJleUtpOXVoMnM0U1h6NGh0Um9oX3htbVYzeTdSLXczYUh2UmMxQjc3c0cyUks3cnhkTDlpRmxrbW5CcEZ1NmR6NUZrVUxhbkRHNHpyZ05hQmdRd1VvTWVIOUJLU0xzYks5c0M1dGd2cmJqRndCYlNKamdJ?oc=5","date":"2013-10-09","type":"pipeline","source":"prnewswire.com","summary":"Novoteris, LLC., Medical Device and Pharmaceutical Product Innovators, Receives Orphan Drug Designation for Nitric Oxide for the Treatment of Cystic Fibrosis - prnewswire.com","headline":"Novoteris, LLC., Medical Device and Pharmaceutical Product Innovators, Receives Orphan Drug Designation for Nitric Oxide","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}